Use of a VEGF antagonist to treat angiogenic eye disorders | Patent Publication Number 20190046609

US 20190046609 A1

Patent NumberUS 10828345 B2

Application Number16159282

Filled DateOct 12, 2018

Priority DateJan 13, 2011

Publication DateFeb 14, 2019

Original AssigneeRegeneron Pharmaceuticals

Current AssigneeRegeneron Pharmaceuticals

Inventor/ApplicantsGeorge D. Yancopoulos

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.